Why is PMN Down Today?

PMN
$4.06
▼ -2.40% ($-0.10)
Last updated: Nov 09, 2026 8:30 PM ET (78 min ago)

About ProMIS Neurosciences Inc. Common Shares (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atroph...

Sector: PHARMACEUTICAL PREPARATIONS
Market Cap: $23.62M
Forward P/E: -0.5
52-Week Range: $0.29 - $27.40
Employees: 8

Overall Confidence: 60%

60% Confident

Based on news, social sentiment, options activity, and sector analysis

SYMPATHY 60% Confidence
🎯 Outperforming sector by 3.7%
This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.

✅ Move Confirmation

LOW VOLUME 0.4x average volume

UNCONFIRMED - Low volume suggests this move may not be sustainable.

📍 Sector Context

PHARMACEUTICAL PREPARATIONS sector: +1.3%

PMN is outperforming its sector by -3.7%. This suggests a stock-specific catalyst.

Market Comparison

PMN is significantly underperforming the market (-4.8% vs SPY)
S&P 500
SPY
+2.37%
Nasdaq 100
QQQ
+3.54%
PMN
This Stock
-2.40%
vs S&P 500: -4.77%
vs Nasdaq: -5.94%

📊 What Happens Next?

Probability Analysis

45% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, PMN is expected to trade between:
$3.94 - $4.14

Key Level to Watch

$3.86 support
Watch for breakdown below $4.06

🔔 Get PMN Alerts

We'll notify you when PMN's trend changes or a new signal fires.

Last updated: Nov 09, 2026 8:30 PM (78 minutes ago)
Data refreshes every 30 minutes during market hours

Historical Context

PMN has moved more than 3.0% down on 64 occasions in the past year.

50.0%
Continuation Rate
32/64 times continued down
+35.57%
Avg Next Day Change
After similar down moves
Last similar move: Nov 02, 2026 (-9.4%) → Next day: +13.7%

Frequently Asked Questions

Why is PMN stock down today?

This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.

Is PMN stock a buy or sell right now?

Based on current analysis, PMN shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →

What is the PMN stock price target?

PMN is currently trading at $4.06. Based on today's momentum, the expected short-term range is $3.94 - $4.14. See long-term price prediction →

Will PMN stock continue falling?

Our analysis shows a 45% probability that PMN's move continues in the next 1-3 days. Key level to watch: $3.86 (support).

Is PMN stock oversold or overbought?

PMN's RSI (Relative Strength Index) is currently at 33.0. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.

What is the momentum for PMN stock?

PMN's 10-day momentum indicator is at -4.01. Strong bearish momentum - the stock is experiencing significant downward pressure. Watch for potential reversal signals.

Is PMN outperforming or underperforming the market?

PMN (-2.40%) is currently significantly underperforming the market (-4.8% vs SPY). Today, the S&P 500 (SPY) is up 2.37%, and Nasdaq (QQQ) is up 3.54%.

What does MACD indicate for PMN?

PMN's MACD (-1.8) is currently below the signal line (-1.48), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 30.1) is strong.

Is PMN in an uptrend or downtrend?

Based on moving average analysis, PMN is in a bearish trend. The price ($4.06) is trading below both the 20-day SMA ($7.08) and 50-day SMA ($9.95). This alignment typically indicates sustained downward pressure.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL